These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2219608)

  • 1. Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
    Kohri K; Kodama M; Katayama Y; Ishikawa Y; Takada M; Kataoka K; Katoh Y; Iguchi M; Kurita T
    Urology; 1990 Oct; 36(4):309-14. PubMed ID: 2219608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperuricosuria and urolithiasis].
    Koide T
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
    Strauss AL; Coe FL; Parks JH
    Arch Intern Med; 1982 Mar; 142(3):504-7. PubMed ID: 7065787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of urinary calculi with thiazides and allopurinol. A long-term study].
    May P; Pilorz H; Duhme C; Pöpperl H; Braun J
    Urologe A; 1984 Mar; 23(2):87-90. PubMed ID: 6426113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
    Hofbauer J; Zechner O
    Eur Urol; 1988; 15(3-4):227-9. PubMed ID: 3215256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of allopurinol in the prevention of recurrent calcium oxalate stones].
    Sonoda T; Koide T; Oka T; Sakaguchi H; Itatani H; Ohkawa T; Ebisuno S; Morimoto S; Yoshida O; Okada Y
    Hinyokika Kiyo; 1985 Nov; 31(11):2071-9. PubMed ID: 4091144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria.
    Ohkawa M; Tokunaga S; Nakashima T; Orito M; Hisazumi H
    Br J Urol; 1992 Jun; 69(6):571-6. PubMed ID: 1638340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in urinary oxalate values by allopurinol.
    Scott R; Paterson PJ; Smith M; Mathieson A
    Urology; 1978 Aug; 12(2):212-4. PubMed ID: 695155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does hyperuricosuria play a role in calcium oxalate lithiasis?
    Ettinger B
    J Urol; 1989 Mar; 141(3 Pt 2):738-41. PubMed ID: 2645432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hyperuricosuric calcium oxalate stone former.
    Sarig S
    Miner Electrolyte Metab; 1987; 13(4):251-6. PubMed ID: 3306317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-uric acid nephrolithiasis.
    Coe FL
    Arch Intern Med; 1978 Jul; 138(7):1090-3. PubMed ID: 666467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol.
    Maschio G; Tessitore N; D'Angelo A; Fabris A; Pagano F; Tasca A; Graziani G; Aroldi A; Surian M; Colussi G; Mandressi A; Trinchieri A; Rocco F; Ponticelli C; Minetti L
    Am J Med; 1981 Oct; 71(4):623-6. PubMed ID: 7282751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
    Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.